Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients

被引:26
|
作者
Koh, Hui Kai [1 ]
Chai, Zi Teng [2 ]
Tay, Hui Wen [1 ]
Fook-Chong, Stephanie [3 ]
Choo, Karen J. L. [2 ]
Oh, Choon Chiat [2 ]
Yeo, Yi Wei [2 ]
Koh, Hong Yi [2 ]
Pang, Shiu Ming [2 ]
Lee, Haur Yueh [2 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Singapore Gen Hosp, Dept Dermatol, Outram Rd, Singapore 169608, Singapore
[3] Singapore Gen Hosp, Hlth Serv Res Unit, Div Med, Singapore, Singapore
关键词
adverse drug reactions; bacteremia; diagnostic markers; microbiology; risk factors; sepsis; Stevens-Johnson syndrome; toxic epidermal necrolysis; RETROSPECTIVE ANALYSIS; UNKNOWN ORIGIN; PROCALCITONIN; EPIDEMIOLOGY; MULTIFORME; GUIDELINES; MANAGEMENT; FEVER;
D O I
10.1016/j.jaad.2019.05.096
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Sepsis is the main cause of death in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objectives: Our aim was to identify admission risk factors predictive of bacteremia and the accompanying clinical or biochemical markers associated with positive blood cultures. Methods: A retrospective cohort study over a 14-year period (2003-2016) was performed. Results: The study included 176 patients with SJS (n = 59), SJS-TEN overlap (n = 51), and TEN (n = 66). During hospitalization, bacteremia developed in 52 patients (29.5%), who experienced poorer outcomes, including higher intensive care unit admission (P < .0005), longer length of stay (P < .0005), and higher mortality (P < .0005). There were 112 episodes of bacteremia, and isolates included Acinetobacter baumannii (27.7%, n = 31) and Staphylococcus aureus (21.4%, n = 24). On multivariate analysis, clinical factors present at admission that were predictive of bacteremia included hemoglobin <= 10 g/dL (odds ratio [OR] 2.4, confidence interval [CI] 2.2-2.6), existing cardiovascular disease (OR 2.10, CI 2.0-2.3), and body surface area involvement >= 10% (OR 14.3, CI 13.4-15.2). The Bacteremia Risk Score was constructed with good calibration. Hypothermia (P = .03) and procalcitonin >= 1 mu g/L (P = .02) concurrent with blood culture sampling were predictive of blood culture positivity. Limitations: This is a retrospective study performed in a reference center. Conclusion: Hemoglobin <= 10 g/dL, cardiovascular disease, and body surface area involvement >= 10% on admission were risk factors for bacteremia. Hypothermia and elevated procalcitonin are useful markers for the timely detection of bacteremia.
引用
收藏
页码:686 / 693
页数:8
相关论文
共 50 条
  • [21] The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Mockenhaupt, Maja
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (06) : 803 - 815
  • [22] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses
    Hanson, Leah M.
    Bettencourt, Amanda P.
    AACN ADVANCED CRITICAL CARE, 2020, 31 (03) : 281 - 295
  • [23] Stevens-Johnson syndrome and toxic epidermal necrolysis
    Steven J. Parrillo
    Current Allergy and Asthma Reports, 2007, 7 : 243 - 247
  • [24] Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Sotelo-Cruz, Norberto
    GACETA MEDICA DE MEXICO, 2012, 148 (03): : 265 - 275
  • [25] Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!
    Kumar, Rajesh
    Das, Anupam
    Das, Sudip
    INDIAN JOURNAL OF DERMATOLOGY, 2018, 63 (02) : 117 - 124
  • [26] Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Cartotto, Robert
    CLINICS IN PLASTIC SURGERY, 2017, 44 (03) : 583 - +
  • [27] Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis
    Wang, Qian
    Tian, Xiao-Bing
    Liu, Wei
    Zhang, Li-Xia
    JOURNAL OF DERMATOLOGY, 2018, 45 (08) : 989 - 993
  • [28] Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis
    Yu, Rentao
    Chen, Shuang
    Pan, Yun
    Ma, Chunrong
    Hu, Li
    Chen, Aijun
    Wei, Bin
    JOURNAL OF DERMATOLOGY, 2022, 49 (06) : 629 - 636
  • [29] Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Epidemiology, Risk Factors, and Predictive Value of Skin Cultures
    de Prost, Nicolas
    Ingen-Housz-Oro, Saskia
    Duong, Tu Anh
    Valeyrie-Allanore, Laurence
    Legrand, Patrick
    Wolkenstein, Pierre
    Brochard, Laurent
    Brun-Buisson, Christian
    Roujeau, Jean-Claude
    MEDICINE, 2010, 89 (01) : 28 - 36
  • [30] Study of ocular manifestations of Stevens-Johnson syndrome/toxic epidermal necrolysis
    Abrol, Arundha
    Gulanikar, Anirudha
    Thakre, Snehal
    Patel, Asim
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (04) : 570 - 574